Research Paper Volume 14, Issue 14 pp 5946—5958
The RIPK family: expression profile and prognostic value in lung adenocarcinoma
Figure 2. The relative expression levels of the RIPK family in LUAD patients and their correlation to clinic stages. (A) GEPIA databases were used to evaluate the relative expression levels of the RIPK family in LUAD patients. (B–F) the correlation between expression of RIPK1-5 and tumor clinic stage.